BioCryst Pharmaceuticals
BCRX
#4899
Rank
C$2.88 B
Marketcap
C$11.30
Share price
-1.85%
Change (1 day)
15.40%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of June 2026 : C$1.12 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is C$1.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$0.60 B-48.21%
2024-12-31C$1.16 B6.04%
2023-12-31C$1.09 B8.78%
2022-12-31C$1.00 B33.08%
2021-12-31C$0.75 B112.14%
2020-12-31C$0.35 B222.34%
2019-12-31C$0.11 B31.28%
2018-12-31C$84.21 M22.41%
2017-12-31C$68.79 M-4.71%
2016-12-31C$72.19 M72.45%
2015-12-31C$41.86 M20.25%
2014-12-31C$34.81 M9.02%
2013-12-31C$31.93 M7.05%
2012-12-31C$29.83 M-2.24%
2011-12-31C$30.51 M
2000-12-31C$0.01 M
1997-12-31C$0.14 M-65.23%
1996-12-31C$0.41 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Gilead Sciences
GILD
C$37.31 B 3,210.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$34.36 B 2,948.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$1.48 B 31.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$0.98 B-12.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$0.42 B-62.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$6.97 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$2.13 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C$11.23 M-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.82 B-26.62%๐Ÿ‡บ๐Ÿ‡ธ USA